Literature DB >> 19801031

Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study).

Claudio Bilato1, Maria-Chiara Corti, Giovannella Baggio, Debora Rampazzo, Ada Cutolo, Sabino Iliceto, Gaetano Crepaldi.   

Abstract

The prevalence of atrial fibrillation (AF) is increasing in older patients faster than that of any other arrhythmia. AF is associated with increased morbidity and mortality. Data on AF in European populations are scarce. The aim of this study was to determine the prevalence and potential predictors of AF and to assess its impact on physical function and mortality in a representative sample of an Italian population >or=65 years of age. One thousand five hundred ninety-nine participants in the Pro.V.A. study, an observational cohort study of Italian subjects >or=65 years old, were assessed for health status, disability, and presence of AF at baseline and at a 4-year follow-up visit. After weighting, prevalence of AF at baseline was 7.4% and increased with advancing age. In subjects with AF, prevalences of stroke, coronary heart disease, peripheral artery disease, cognitive impairment, and physical disability were significantly higher (p <0.01) than in those without AF. In patients with AF, 34% had heart failure compared to 5.3% of those without AF (p <0.0001). In multivariate logistic regression, heart failure was associated with a fivefold risk of AF (odds ratio 5.09, 95% confidence interval 3.20 to 8.11). In Cox analysis, AF was an independent risk factor for mortality. After adjustment for potential confounders, the hazard ratio for mortality associated with AF was 1.47 (95% confidence interval 1.08 to 1.99). In conclusion, in subjects >or=65 years old, AF is strongly associated with heart failure, is an independent risk factor for mortality, and, in the presence of physical disability, could be considered a severity measurement of disability.

Entities:  

Mesh:

Year:  2009        PMID: 19801031     DOI: 10.1016/j.amjcard.2009.05.058

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Cognitive impairment associated with atrial fibrillation: a meta-analysis.

Authors:  Shadi Kalantarian; Theodore A Stern; Moussa Mansour; Jeremy N Ruskin
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

2.  Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.

Authors:  Irene Marzona; Martin O'Donnell; Koon Teo; Peggy Gao; Craig Anderson; Jackie Bosch; Salim Yusuf
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

Review 3.  Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Authors:  Francesco Violi; Gregory Y H Lip; Stefania Basili
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

Review 4.  Early management of atrial fibrillation: from imaging to drugs to ablation.

Authors:  Ashok J Shah; Xingpeng Liu; Amir S Jadidi; Michel Haïssaguerre
Journal:  Nat Rev Cardiol       Date:  2010-04-27       Impact factor: 32.419

Review 5.  Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.

Authors:  Stefano Bordignon; Maria Chiara Corti; Claudio Bilato
Journal:  J Atr Fibrillation       Date:  2012-06-15

6.  The involvement of pharmacies in the screening of undiagnosed atrial fibrillation.

Authors:  Pietro Amedeo Modesti; Gianni Donigaglia; Plinio Fabiani; Nicola Mumoli; Andrea Colella; Maria Boddi
Journal:  Intern Emerg Med       Date:  2017-09-19       Impact factor: 3.397

7.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

Authors:  Bouwe P Krijthe; Anton Kunst; Emelia J Benjamin; Gregory Y H Lip; Oscar H Franco; Albert Hofman; Jacqueline C M Witteman; Bruno H Stricker; Jan Heeringa
Journal:  Eur Heart J       Date:  2013-07-30       Impact factor: 29.983

8.  Downregulated protein expression of transcriptional activator ELK-1 in atrial myocardium of chronic AF patients.

Authors:  Xiangjun Zeng; Xuejun Xiao; Yueheng Wu; Huanlei Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation.

Authors:  Andrea Tampieri; Anna Maria Rusconi; Tiziano Lenzi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

10.  Falls and Atrial Fibrillation in Elderly Patients.

Authors:  Chen-Ying Hung; Tsu-Juey Wu; Kuo-Yang Wang; Jin-Long Huang; El-Wui Loh; Yi-Ming Chen; Chu-Sheng Lin; Ching-Heng Lin; Der-Yuan Chen; Yih-Jing Tang
Journal:  Acta Cardiol Sin       Date:  2013-09       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.